NEWSBRIEF: The first European LDN Conference, to be held in Scotland on April 25th, will bring together authorities from around the world to discuss low-dose naltrexone (LDN) as a possible treatment for several immune system-related illnesses.
The organizer, Dr. Tom Gilhooly of the Essential Health Clinic in Glasgow, says emerging research is supporting and validating anecdotal claims that LDN works well for fibromyalgia, chronic fatigue syndrome, multiple sclerosis, Crohn's disease, and more.
More information on the conference is available online at Glasgow LDN Conference 2009.
__________________________
Stay up to date: subscribe to my free
and get support and information in our
__________________________
Comments
No comments yet. Leave a Comment
